The JDRF Industry Discovery & Development Partnership (IDDP) program is intended to provide support to for-profit entities for research programs that are closely aligned with JDRF’s priority areas. IDDP projects accelerate the discovery, development and commercialization of therapeutics and devices for the treatment, cure, and prevention of type 1 diabetes. IDDPs are intended to foster long-term collaborative relationships between JDRF, industry partners, and the T1D community.
The IDDP program combines the capabilities of for-profit entities in translating therapies to commercialization with JDRF’s capabilities and network as a patient advocacy organization and the largest non-governmental funder of T1D research worldwide.
The IDDP mechanism is intended for biotechnology, pharmaceutical, device companies or other for-profit entities, either public or private. Projects may include company partnerships with academic investigators, CROs or other entities that enhance the research project. There are no geographical restrictions.
The industry partner must propose a project focused on the discovery, development, and commercialization of therapeutics and/or devices to cure, treat and/or prevent type 1 diabetes. Projects may be pre-clinical or clinical.
JDRF expects industry partners to demonstrate a commitment to carry IDDP projects/programs to commercialization in order to have a meaningful impact for the T1D community. Applicant companies will be required to commit funding to the project in an amount equal to or greater than the amount requested from JDRF. In addition, companies will be asked to provide audited financial statements and fiscal projections for, at minimum, the duration of the proposed research project. The company has to demonstrate that the JDRF-supported program will remain a going concern for the company after the conclusion of IDDP funding.
Information on JDRF’s Research Priority Areas may be found under the “For Applicants” tab at http://grantcenter.jdrf.org. The page also includes information on JDRF’s current Requests for Applications (RFAs), which may include opportunities for companies. Potential industry partners are advised to consult with JDRF staff to discuss alignment with JDRF priorities and IDDP program requirements and processes.
Applications may be submitted in response to periodic Requests for Applications (RFAs) or by invitation from JDRF on a rolling basis. All application materials must be submitted via JDRF’s electronic portal, RMS360. All submissions are confidential.
IDDP application process:
-JDRF Partnerships staff will work with the JDRF Research team to determine project eligibility and alignment to JDRF program goals
-The LOI is intended to be a concise description of the goal, timeframe and estimated cost of the proposed study and its relevance to the JDRF mission. A history of the company together with the biographical sketches of the company’s principals and scientific investigators is requested with the LOI.
-JDRF will notify the applicant of the review outcome. A successful LOI review is required for submission of a full proposal.
-The applicant should work with their JDRF contact(s) in submitting a full application
-All proposals will undergo external peer review. Proposals with a successful review outcome will undergo standard JDRF governance processes.
Non-exclusivity: It is understood that JDRF will continue to accept submissions and support activities across the field, including at non-profit and for-profit competing organizations.
IDDP projects are governed by an agreement negotiated between the parties. All aspects of the relationship are described in the agreement, including but not limited to the following:
1) Research scope and study design
2) Key personnel and collaborators
3) Project milestones, budget and payment schedule (payments are milestone-based)
4) Reporting obligations and arrangements for project governance
-JDRF expects to have representation on a joint steering committee for the project
6) Intellectual property
-Company will own all funded research discoveries, IP and product rights. If Company decides to abandon further development and commercialization activities, JDRF will have access to IP developed during the funded research program with the right to sublicense to another entity committed to the necessary development and commercialization. JDRF will share with company any upsides.
7) Commercialization and royalties
-JDRF will receive a modest ROI, based on Company’s successful commercialization of products (or other inflection point as mutually agreed in the IDDP contract) derived from the funded research program. Royalty rates & cap will depend on the stage of development and level of risk
8) Publications and Presentations
10) Term and Termination
11) (if applicable) JDRF Terms & Conditions for funding of research involving human clinical trials
JDRF Research Partnerships:
Olivia Lou, Ph.D. (firstname.lastname@example.org); Richard McGregor, Ph.D. (email@example.com)
Note: The IDDP process is managed by JDRF Research (jdrf.org). Opportunities for companies are also available through the JDRF T1D fund (t1dfund.org), a mission-driven venture philanthropy fund.